Skip to main content
. 2019 Jul 12;24(11):e1044–e1054. doi: 10.1634/theoncologist.2018-0697

Figure 2.

image

MiR‐106b is a specific biomarker for CTC phenotypes. Correlation of the expression of miR‐106b with vimentin (A, n = 128) and E‐cadherin (B, n = 128). (C): Quantification of miR‐106b by real‐time quantitative polymerase chain reaction in TNBCs (n = 16) and non‐TNBCs (n = 112).

Abbreviations: CTC, circulating tumor cell; TNBCs, triple‐negative breast cancers.